- Home
- Articles
- latamerica
- bone marrow cell
Bone Marrow Cell Articles & Analysis: Older
24 articles found
By administering recombinant chemokines, scientists can redirect immune cells to the tumor microenvironment, potentially enhancing the efficacy of checkpoint inhibitors or CAR-T cell therapies. ...
The Latest Technological Advances in Antibody Discovery1. Single B Cell Isolation and SequencingThe isolation and sequencing of single B cells can help us gain a deeper understanding of the diversity and specificity of B cells. ...
In-vivo test results have histologically demonstrated the presence of all 5 bone-forming elements (Chondrocytes, Osteocytes, Bone Marrow Cells, Cartilage, and New Bone). ...
The three main components of tissue engineering applications are scaffold, cell and growth-stimulating signals. Collagen has been widely used in the clinical field due to its abundance in nature, biocompatibility, low antigenicity and biodegradability. ...
Cytokines are a broad class of tiny proteins that are essential for controlling inflammation and immunological responses. Numerous cell types, including fibroblasts, endothelial cells, immunological cells, and epithelial cells, produce these signaling molecules. ...
Particularly noteworthy are bone marrow mesenchymal stem cells (BM-MSCs), a subtype of MSCs. Their unique properties make them indispensable resources for developing ground-breaking solutions for various medical conditions. ...
IL-17D IL-17D is expressed in many cells and organs, but its expression in immune cells such as lymphocytes and monocytes is weak. IL-17D induces endothelial cells to produce IL-6, IL-8, and GM-CSF. It also has an inhibitory effect on hematopoiesis of bone marrow precursor cells. ...
IL-36 is mainly distributed in skin, lungs, joints, intestines, kidneys, and the brain, and can be produced by various cells such as monocytes/macrophages, T lymphocytes, B lymphocytes, keratinocytes, M2 cells, Langerhans cells, etc. IL-36 beta can activate M2-like macrophages and Langerhans cells; in bone ...
There are a ton of practical uses for computer vision at present times. One industry where this technology is increasingly useful in healthcare. It is impossible to exaggerate the value of computer vision services in the medical field. Its methods continue to be used more widely since they have demonstrated excellent utility in numerous medical contexts, including surgical planning and medical ...
Multiple myeloma (multiple myeloma, MM) is a malignant tumor originating from the B cell lineage, characterized by the clonal proliferation of malignant plasma cells in the bone marrow microenvironment, causing fractures and bone marrow failure, and is the second most common blood system disease ...
Service type: Knock-in mice Abstract Vaccines work largely by generating long-lived plasma cells (LLPCs), but knowledge of how such cells are recruited is sparse. Although it is clear that LLPCs preferentially originate in germinal centers (GCs) and relocate to survival niches in bone marrow where they can persist for decades, ...
The innovation of this treatment is the use of umbilical cord blood stem cells—the two previous cured cases used hematopoietic stem cells from adult bone marrow, while umbilical cord blood stem cells are more readily available and have less stringent mating requirements, so they are expected to be used in ...
Anderson is particularly excited about the preclinical progress in targeting blood and immune cell precursors in bone marrow demonstrated by companies such as Beam Therapeutics and Intellia in Cambridge, both of which are using specially designed formulations of lipid nanoparticles. Success in targeting those tissues, he says, could spare ...
Simply put, CAR-T is to transform the patient's immune T cells in vitro by biotechnology, so that they recognize antigens on the surface of tumor cells, and then inject these cells back into the patient to achieve the therapeutic effect of recognizing and killing cancer cells. ...
Researchers from IRCCS Istituto Ortopedico Rizzoli and Indian Institute of Technology, Delhi (IIT) used their REGENHU bioprinters to fabricate an in vitro phenotypically stable engineered articular cartilage by embedding human bone marrow-derived stromal cells (hMSCs) in a cell-laden silk fibroin–gelatin (SF-G) bioink. ...
ByRegenhu
This dual approach was observed to provide higher level of vascularization and new bone formation in vivo. While applied in this case for bone regeneration, this technique could be easily adapted to prevascularise scaffolds to target regeneration of any tissue and organs. ...
ByRegenhu
The Indian Medical Devices industry is mostly import-dependent with no specific regulations in place till recent times. With the introduction of MDR (Medical Device Rules 2017) attempt has been made to harmonize the Indian medical device Industry as per globally prevailed ...
SAN FRANCISCO, CA--(Marketwired - Sep 11, 2015) - Aelan Cell Technologies announced today the addition of Meenakshi Gaur, Ph.D. to their stem cell clinical program. ...
Post-irradiation administration of POLY MVA to mice resulted in faster cellular DNA repair, as revealed from the increased Cellular Repair Index (CRI) of blood leukocytes and bone marrow cells. Exposure of mice to 2 Gy whole-body gamma radiation resulted in the formation of strand breaks of cellular DNA of bone ...
Post-irradiation administration of POLY MVA to mice resulted in faster cellular DNA repair, as revealed from the increased Cellular Repair Index (CRI) of blood leukocytes and bone marrow cells. Exposure of mice to 2 Gy whole-body gamma radiation resulted in the formation of strand breaks of cellular DNA of bone ...